CreativeOne Wealth’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-66
Closed -$1K 786
2022
Q3
$1K Sell
66
-7
-10% -$245 ﹤0.01% 693
2022
Q2
$4K Hold
73
﹤0.01% 711
2022
Q1
$10K Hold
73
﹤0.01% 729
2021
Q4
$12K Sell
73
-35
-32% -$13.1K ﹤0.01% 744
2021
Q3
$54K Sell
108
-5
-4% -$2.32K ﹤0.01% 687
2021
Q2
$56K Buy
113
+4
+4% +$2.15K ﹤0.01% 669
2021
Q1
$55K Buy
109
+2
+2% +$1.03K ﹤0.01% 560
2020
Q4
$51K Buy
107
+35
+49% +$11.5K ﹤0.01% 501
2020
Q3
$21K Buy
72
+11
+18% +$2.73K ﹤0.01% 265
2020
Q2
$12K Buy
61
+24
+65% +$3.99K ﹤0.01% 243
2020
Q1
$5K Hold
37
﹤0.01% 195
2019
Q4
$6K Buy
+37
New +$4.78K ﹤0.01% 221

Other funds holding AMPE

CreativeOne Wealth's AMPE Position: Q4 2022 in Review

CreativeOne Wealth sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 66 shares — an estimated $1K sold.

CreativeOne Wealth first reported a position in AMPE in Q4 2019 and held it in 12 quarters. The position peaked at $56K in Q2 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • CreativeOne Wealth reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • CreativeOne Wealth sold 66 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • CreativeOne Wealth first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 12 quarters.
  • CreativeOne Wealth's Ampio Pharmaceuticals Inc. position peaked at $56K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on CreativeOne Wealth's 13F filing for Q4 2022, filed 15 Feb 2023.